Beginning Cash: The amount of cash reported by the company on its previous statement.
China SXT Pharmaceuticals, Inc. (SXTC) had Beginning Cash of $18.13M for the most recently reported fiscal year, ending 2026-03-31.
| Income Statement Financials | |
$1.14M |
|
$-6.21M |
|
$0.89M |
|
$0.25M |
|
$8.26M |
|
$-7.12M |
|
$0.92M |
|
$-6.21M |
|
$-6.21M |
|
$-6.21M |
|
$-6.21M |
|
$-6.21M |
|
$-6.21M |
|
$-7.12M |
|
$-7.05M |
|
0.68M |
|
0.68M |
|
$-9.13 |
|
$-9.13 |
|
| Balance Sheet Financials | |
$34.51M |
|
$0.12M |
|
$0.24M |
|
$34.75M |
|
$4.35M |
|
$0.64M |
|
$0.70M |
|
$5.05M |
|
$29.71M |
|
$29.70M |
|
$29.71M |
|
0.96M |
|
| Cash Flow Statement Financials | |
$-4.02M |
|
$-1.25M |
|
$14.43M |
|
|
Beginning Cash |
$18.13M |
$28.18M |
|
$10.05M |
|
$5.31M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
7.93 |
|
-- |
|
-- |
|
0.02 |
|
0.03 |
|
21.85% |
|
-625.89% |
|
-625.89% |
|
-619.41% |
|
-545.24% |
|
-545.24% |
|
$-4.02M |
|
-- |
|
-- |
|
-- |
|
0.03 |
|
1.14 |
|
0.38 |
|
963.75 |
|
-20.89% |
|
-20.89% |
|
-17.85% |
|
-20.44% |
|
$31.01 |
|
$-5.91 |
|
$-5.91 |
|